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Abstract 
A 64-year-old man with nephrotic syndrome was admitted to another hospital where his renal 
biopsy revealed membranoproliferative glomerulonephritis (MPGN) with monoclonal 
immunoglobulin (Ig) G, subclass 1, κ light chain (IgG1κ) deposition on immunofluorescence (IF). 
Proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) was suspected due to 
monoclonal IgG1κ deposits and the absence of hematological abnormalities. However, the typical 
PGNMID phenotype was not observed by electron microscopy. Instead, an organized and striated 
muscle-like structure was observed in the subendothelial space. Since a 2-year treatment with 
immunosuppressants did not improve his proteinuria, a second biopsy was performed at our 
hospital. It showed an MPGN-like phenotype; however, monoclonal immunoglobulin deposits on IF 
were no longer observed. One year after the second biopsy, he developed end-stage renal disease. 
Thus, he underwent living kidney transplantation from his wife. Allograft biopsy was performed as 
proteinuria was observed 3 months after transplantation, which again showed an MPGN-like 
phenotype with monoclonal IgG1κ deposits. The observed electron-dense deposits were similar to 
those in the native biopsies. Accordingly, the patient was diagnosed with recurrent MPGN. Adding 
methylprednisolone pulse therapy to conventional immunosuppressants did not improve the 
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patient’s renal function or proteinuria. He died of Legionella pneumonia 8 months after 
transplantation. Considering the patient’s histological findings of MPGN with monoclonal IgG1κ 
deposits and early recurrence of glomerulonephritis after transplantation, he was diagnosed with 






Recurrent glomerulonephritis has attracted attention as a cause of graft loss after kidney 
transplantation in recent advancements in immunosuppressive treatment [1,2]. 
Membranoproliferative glomerulonephritis (MPGN) with monoclonal immunoglobulin deposits 
shows a higher recurrence rate after transplantation than MPGN with polyclonal immunoglobulin, 
with subsequent progression to graft loss [3]. 
Proliferative glomerulonephritis with monoclonal immunoglobulin G (IgG) deposits (PGNMID), 
described by Nasr et al. [4], is characterized by MPGN-like histological findings and glomerular 
deposition of monoclonal immunoglobulin. However, only 10%–30% patients with PGNMID have M 
protein [5,6]. A recent study revealed that PGNMID frequently recurs early after transplantation.  
We present a case of recurrent PGNMID with a novel and unclassified organized glomerular 
structure. 
Case Report 
Clinical course of a native kidney 
A 64-year-old Japanese man was hospitalized with lower leg edema. Although proteinuria had 
been noted 3 years before admission, he had not received treatment. No remarkable family history 
was noted. Upon admission, the patient’s blood pressure was 179/119 mmHg; urinalysis showed 
proteinuria of 9.4 g/g Creatinine (Cr) and hematuria (2+). Laboratory examination revealed the 
following: serum Cr, 1.45 mg/dL; total protein, 4.1 g/dL; albumin, 1.7 g/dL; low-density lipoprotein, 
208 mg/dL; and IgG, 627 mg/dL. Serum complement levels were within the normal ranges. Light 
microscopy of the first renal biopsy specimen revealed lobular glomerular alterations with 
mesangial and endocapillary hypercellularity and glomerular basement membrane duplication, 
typical of MPGN. Immunofluorescence (IF) revealed weak glomerular staining for IgG, IgM, C3, C1q, 
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and fibrinogen, with a peripheral capillary pattern. Subsequent immunostaining for IgG subclasses 
and light chains revealed monoclonal IgG1κ deposition with a similar peripheral pattern. Despite 
monoclonal IgG1κ deposition in the glomeruli, M protein was not detected in the blood or urine, 
and there was no evidence of plasma cell dysplasia. Electron microscopy revealed the accumulation 
of organized deposits with a striated pattern in the subendothelial space and mesangial area, 
atypical for MPGN. These electron-dense bands were 10–12-nm wide with a 25–30-nm distance of 
periodicity. Markers of secondary MPGN, including antinuclear antibody, cryoglobulin, and 
antibodies for hepatitis B and C, were not detected. The patient was diagnosed with primary MPGN, 
and oral prednisolone (35 mg/day) was administered. Considering that 1-year immunosuppressive 
treatment was not effective in improving the patient’s proteinuria and renal dysfunction, he was 
referred to our hospital, and a second biopsy was performed 2 years after the first biopsy. 
Findings on the second biopsy were similar to those of the first biopsy, except for IF results; 
different from the first biopsy, no significant staining for immunoglobulin or complement was 
observed. The second biopsy specimen included a higher percentage of sclerotic glomeruli (27%) 
than the first biopsy specimen (15%). Moreover, the glomeruli of the second biopsy specimen on IF 
were more sclerotic compared to those of the first biopsy specimen, and the deposition could not be 
detected. This probably explains the discrepancy in terms of monoclonal deposition between the 
first and second biopsies. There was no evidence of a hematological disorder or secondary MPGN. 
Subsequent 1-year immunosuppressive treatment did not improve patient’s renal function, and 
hemodialysis was initiated.  
Clinical course of the allograft kidney 
Two years later, at the age of 68, he underwent ABO-incompatible living kidney transplantation 
(blood type A to O) from his 68-year-old wife. For preoperative desensitization, rituximab (200 
mg/body) was administered 2 weeks before transplantation, and 2 sessions of plasmapheresis 
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followed by plasma exchange (PE) were performed. Baseline allograft biopsy showed no significant 
abnormality except for mild arteriosclerosis. A maintenance immunosuppressive regimen included 
prednisolone, tacrolimus (TAC), and mycophenolate mofetil (MMF). Serum Cr increased from 1.29 
mg/dL to 2.37 mg/dL 3 weeks after transplantation. The second allograft biopsy, which was 
performed 3 weeks after transplantation, showed endocapillary proliferation and peritubular 
capillaritis without mesangial proliferation. Although we found positive staining for C4d on the 
peritubular capillaries on immunohistochemistry, these results might be attributed to ABO-
incompatible kidney transplantation. Considering the absence of positive staining for 
immunoglobulin and complements on IF, these findings were consistent with active antibody-
mediated rejection. Methylprednisolone pulse therapy and rituximab were included in the 
maintenance therapy, followed by 2 sessions of PE and 6 g of intravenous immunoglobulin. The 
additional treatment restored serum Cr to 1.51 mg/dL and the patient was discharged. Two months 
after discharge, his proteinuria protein level increased to 6.8 g/gCr with a slight increase in serum 
Cr level to 1.75 mg/dL. Hence, we performed a third allograft biopsy 3 months after 
transplantation. Light microscopy revealed the absence of sclerotic glomeruli; however, more than 
half of the 23 glomeruli showed mesangial proliferation with nodules, which were negative for 
Congo red staining. Endocapillary proliferation and cellular crescents were also observed in some 
glomeruli, with segmental glomerular basement membrane duplication (Fig. 1). Mild interstitial 
fibrosis, tubular atrophy, and intimal fibroelastosis were observed, with no evidence of rejection. 
No immunoglobulin or complement was detected on IF-stained frozen tissues. 
Immunohistochemistry of paraffin-embedded tissues digested with proteinase revealed 
monoclonal IgGκ1 deposits, with peripheral and mesangial patterns (Fig. 2). Electron microscopy 
revealed a few dense deposits with striated ultrastructure in the subendothelial space and 
paramesangial area, similar to those observed in the native kidney biopsies (Fig. 3). Accordingly, 
the patient was diagnosed with recurrent glomerulonephritis. Methylprednisolone pulse therapy 
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was added to maintenance immunosuppressive therapy for the treatment of proteinuria (4–6 
g/gCr) and kidney disease as evidenced by the elevated serum Cr level of 2.38 mg/dL. At 8 months 
after transplantation, the patient was admitted following the complaints of fever and dyspnea, and 
he was diagnosed with Legionella pneumonia. Antibiotics were ineffective, and he subsequently 
died. 
Discussion 
We report a case of novel MPGN with monoclonal immunoglobulin deposits and recurrence early 
after transplantation. Proteinuria was observed 1 month after transplantation, and histological 
recurrence was confirmed with a protocol biopsy performed 3 months later. 
Based on the pathological features of MPGN and monoclonal immunoglobulin deposits in the 
glomeruli, with the absence of M protein, this case met the criteria for PGNMID described by Nasr et 
al. [4]. Features observed on electron microscopy typical of PGNMID include unorganized granular 
deposits localized to the subendothelial space, the mesangial area, and/or the subepithelial space. 
The clinical outcomes are variable, with approximately 25% of patients developing end-stage renal 
disease refractory to immunosuppressive treatment within 2.5 years [7]. A recent study of protocol 
biopsies revealed that PGNMID had a high recurrence rate (89%) early after transplantation. In this 
study, approximately half of the patients lost graft function within 3 years after diagnosis [6]. 
Kawanishi et al. reported a case of recurrent PGNMID leading to rapid graft loss after 
transplantation [8]. Considering a high recurrence rate and poor prognosis, careful consideration is 
required to perform kidney transplantation for patients progressing to end-stage renal disease due 
to PGNMID. 
The presence of monoclonal immunoglobulin deposits in the kidney is highly suggestive of the 
presence of underlying B-cell or plasma cell clones. Renal diseases with monoclonal 
immunoglobulin are likely to recur after transplantation due to impaired eradication of small B-cell 
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clones. PGNMID has a shorter time to recurrence than light chain amyloidosis and monoclonal 
immunoglobulin deposition disease (MIDD). Despite monoclonal immunoglobulin deposits in the 
kidney, repeated hematological evaluations failed to detect significant abnormalities. Only 10%–
30% patients with PGNMID had detectable M protein in the serum and urine electrophoresis (EP) 
or immunofixation [5,6]. A possible explanation is that the amount of monoclonal immunoglobulin 
was significantly small for detection using the serum or urine EP due to a few underlying B-cell 
clones. 
This case showed unusually organized deposits exclusively in the glomeruli on electron 
microscopy. The deposits contained regularly stacked electron-dense bands in a parallel 
arrangement, resembling striated myofibrils. Organized patterns of fibrils, microtubules, and 
granular deposits have typically been observed in renal diseases [9]. The striated structure 
observed in the present case was different and could not be conventionally classified. Although the 
present case showed ultrastructure similar to fibrin tactoids, its periodicity (25–30 nm) was 
slightly longer than that of fibrin tactoids (22–23 nm) [10]. Some studies have reported cases of 
renal disease with similar ultrastructure [11,12]. The patient’s medical story before transplantation 
in this present case report was summarized in another paper [13]. There was no evidence of 
systemic disease such as cryoglobulinemia, except for 1 case with multiple myeloma. On light 
microscopy, all cases showed similar features, with negative Congo red staining results and MPGN-
like findings. The IF results varied. Some cases were positive for C3 and C1q, while others showed 
no positive findings. 
The present case showed similar electron-dense deposits with a striated ultrastructure, but 2 
unique features were observed. First, this patient relapsed after ABO-incompatible transplantation, 
suggesting pathology refractory to conventional immunosuppressants including TAC and MMF and 
to rituximab and PE, although a recent study reported the efficacy of clone-directed therapy that 
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included rituximab [14]. Second, we found monoclonal deposits using antigen retrieval. 
Conventional IF was negative for immunoglobulins and complements. However, IgG1κ deposition 
was unmasked on immunohistochemistry by protease digestion using paraffin-embedded formalin-
fixed tissue. Similar false-negative cases were reported in studies showing the usefulness of antigen 
retrieval [15]. In cases of MPGN negative for immunoglobulin on IF, unmasking by antigen retrieval 
should be considered.  
A case of PGNMID with another atypical organized deposit was reported [16]. The appearance of 
the deposits in this case was microlamellar, which was different from the striated muscle-like 
structure observed in the present case. Considering the definition of PGNMID by Nasr et al., cases 
with unusual deposits can be diagnosed as atypical PGNMID. Further investigation is needed to 
elucidate the identity of these deposits. 
In conclusion, we report a case of recurrent PGNMID with atypical electron-dense deposits. This is 
the first report of early recurrence of atypical PGNMID with a striated ultrastructure after 
transplantation. To detect monoclonal immunoglobulin deposits with negative staining on IF, 
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Fig. 1. Light microscopic findings of the third allograft biopsy 3 months after 
transplantation. (a) The glomerulus showing mesangial hypercellularity and nodules (periodic 
acid-Schiff staining, 400×). (b) Double-contour glomerular basement membrane and mesangial 
interposition (Jones silver methenamine, 400×). (c, d) The glomerulus with a crescent (c) and 
endocapillary hypercellularity (d) (Jones silver methenamine, 400×). 
 
Fig. 2. Immunohistochemistry of paraffin-embedded tissues digested with proteinase for 
the third allograft biopsy specimens 3 months after transplantation. Monoclonal 
immunoglobulin G, subclass 1, κ light chain deposits with peripheral and mesangial pattern. 
(400×). 
 
Fig. 3. Electron microscopic findings of the second biopsy of the native kidney (A, B) and 
the third allograft biopsy 3 months after transplantation (C, D). (A) Electron-dense deposits 
accumulated in the subendothelial space (3,000×). (B) Higher magnification of deposits 
showing striated myofibril-like ultrastructure (20,000×). (C) Some electron-dense deposits 
(arrow) were observed in the subendothelial space in the allograft biopsy (3,000×). (D) Higher 
magnification of deposits in the allograft biopsy specimen, similar to those in the native kidney 
(15,000×). The width and distance of periodicity of these electron-dense bands were 
approximately 10–12 nm and 25–30 nm, respectively. 
 
